News Column

PHARMACYCLICS INC FILES (8-K) Disclosing Regulation FD Disclosure, Financial Statements and Exhibits

May 7, 2014

Item 7.01. Regulation FD Disclosure.

On May 2, 2014, Pharmacyclics, Inc. (the "Company") held its quarterly earnings call to discuss the financial results from its first quarter ended March 31, 2014. A copy of the transcript of the Company's earnings call is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

The information in this Current Report on Form 8-K, including the exhibit hereto, shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities thereof, nor shall it be deemed to be incorporated by reference into future filings by the Company under the Exchange Act or under the Securities Act of 1933, as amended, except to the extent specifically provided in any such filing.

Item 9.01 Financial Statements and Exhibits. (d) Exhibits.

Exhibit No. Description

99.1 May 2, 2014 Earnings Call Transcript


For more stories on investments and markets, please see HispanicBusiness' Finance Channel

Source: Edgar Glimpses